Skip to main content
. Author manuscript; available in PMC: 2020 Nov 17.
Published in final edited form as: Handb Exp Pharmacol. 2014;225:37–69. doi: 10.1007/978-3-662-44519-8_3

Table 3.

Meta-analysis 1: reductions during paina

Name x y z Voxels Studies active (%)
Height-corrected FWE p < 0.05 Left amygdala −24 −4 −8 60 37.73
Insula, L Middle −38 8 −2 63 37.25
Insula, L Posterior −36 −10 0 233 44.42
−38 −6 10 26 44.42
Insula, L dorsal posterior/Rolandic Operculum/OP4 −48 −10 12 5 25.64
SII, L (Rolandic Operculum/OP1) −46 −22 14 4 27.28
Insula, R Middle 44 10 −2 3 25.61
44 6 10 48 29.13
Putamen, L −30 −18 8 12 27.53
Thalamus, L (Premotor) −14 −18 −2 109 40.1
Extent-corrected p < 0.001 SMA, L −8 0 46 137 25.07
Cingulate, L Middle 0 −2 40 559 25.07
Thalamus, L −12 −22 12 346 32.44
Rolandic Operculum, L −50 4 10 110 34.22
Thalamus, L −6 −10 6 41 27.35
Thalamus, Medial 0 −24 8 45 27.11
Superior temporal gyrus, L (TE 1.0) −42 −20 4 257 30.73
Insula, L Middle −44 −4 −2 216 39.52
Pallidum, L −26 −12 0 176 50.18
Insula, L −36 −20 −4 96 35.35
Hippocampus, L −34 −8 −12 197 38.05
−22 −14 −16 68 24.62
Superior temporal gyrus, L −42 2 −14 207 22.97
Insula, R Middle/Rolandic Operculum (OP4) 52 −6 12 88 21.14
34 8 6 153 37.06
52 0 4 209 24.59
42 −6 6 234 24.59
Putamen, R 30 0 −6 138 41.42
Amygdala, R 28 −6 −14 91 21.72
30 4 −16 120 19.6
a

This table reports clusters and contiguous subclusters corresponding to Fig. 2b